Ralph DeFronzo of the University of Texas Health Science Center, a leading metformin researcher, has noted: "The drugs that genuinely alter metformin pharmacokinetics are those that change renal hemodynamics or compete at the organic cation transporter level
While numerous pathogenic mechanisms and potential targets have been identified, most mechanistic evidence (approximately 90%) relies on rodent models (e.g., mice, rats), representing a critical limitation
pH test
Table 2 [i] The adjusted mean differences and p-values were calculated using multiple linear regression analyses with adjustment for age, physical activity, alcohol intake, body mass index, estimated glomerular filtration rate, diabetes, hypertension, and dyslipidemia